Sunshine Biopharma Inc. SEC filings SBFM
Sunshine Biopharma Inc. has 428 filings in SEC EDGAR's recent list, going back to May 25, 2007. Its latest annual report, Form 10-K, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Oct 14, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 9, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 16, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 11, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 20, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 10, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2026 | May 28, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 19, 2026 | May 18, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 9, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Other events
|
Mar 9, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Feb 20, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 12, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Auditor change
|
Sep 30, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Results of operations
|
May 19, 2025 | May 15, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 3, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 2, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 15, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 19, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 12, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Other events
|
Jul 1, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Other events
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 7, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Results of operations
|
May 22, 2024 | May 21, 2024 |
| 8-K |
Current report
Auditor change
|
May 8, 2024 | May 7, 2024 |
| 8-K |
Current report
Auditor change
|
May 6, 2024 | May 3, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 23, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Shareholder vote results
|
Mar 6, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 1, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Feb 16, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 15, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 12, 2024 | Feb 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 30, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 7, 2023 | Dec 7, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Agreement ended
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 20, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Oct 13, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Other events
|
Sep 22, 2023 | Sep 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 16, 2023 | May 12, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 19, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Listing notice
|
Mar 24, 2023 | Mar 24, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 28, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Other events
|
Feb 13, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 10, 2023 | Feb 7, 2023 |
| 8-K/A | Amended current report | Dec 12, 2022 | Oct 20, 2022 |
| 8-K |
Current report
Listing notice
|
Dec 9, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Oct 20, 2022 | Oct 20, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 28, 2022 | Apr 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2022 | Apr 8, 2022 |
| 8-K |
Current report
Other events
|
Mar 24, 2022 | Mar 24, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 15, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 25, 2022 | Feb 18, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 17, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 10, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 8, 2022 | Feb 7, 2022 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Dec 22, 2021 | Dec 20, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 3, 2021 | Oct 31, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 19, 2020 | Oct 6, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 15, 2020 | Sep 14, 2020 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Jun 24, 2020 | Jun 17, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 3, 2020 | May 22, 2020 |
| 8-K |
Current report
Other events
|
Apr 13, 2020 | Apr 13, 2020 |
| 8-K |
Current report
Agreement ended
|
Jul 19, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 12, 2019 | Mar 12, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 14, 2018 | Sep 10, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 4, 2018 | Jan 1, 2018 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 5, 2017 | Aug 29, 2017 |
| 8-K |
Current report
Other events
|
Jun 23, 2017 | Jun 22, 2017 |
| 8-K/A |
Amended current report
Unregistered share sale
|
Aug 9, 2016 | Jul 8, 2016 |
| 8-K |
Current report
Unregistered share sale
|
Aug 1, 2016 | Jul 8, 2010 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 14, 2016 | Mar 14, 2016 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 28, 2015 | Dec 28, 2015 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 9, 2015 | Oct 8, 2015 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 4, 2015 | Aug 4, 2015 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change
|
Jun 1, 2015 | May 27, 2015 |
| 8-K |
Current report
Officer or director change
|
Feb 24, 2015 | Feb 20, 2015 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 19, 2014 | Nov 14, 2014 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 28, 2014 | Apr 23, 2013 |
| 8-K |
Current report
Auditor change
|
Feb 25, 2013 | Feb 25, 2013 |
| 8-K |
Current report
Other events
|
Nov 29, 2012 | Nov 28, 2012 |
| 8-K/A |
Amended current report
Auditor change
|
Feb 7, 2012 | Jan 30, 2012 |
| 8-K |
Current report
Auditor change
|
Feb 3, 2012 | Jan 30, 2012 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 27, 2011 | Dec 21, 2011 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 17, 2011 | Jun 14, 2011 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 20, 2011 | Jan 20, 2011 |
| 8-K |
Current report
Unregistered share sale
|
Jun 3, 2010 | Jun 2, 2010 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 22, 2010 | Jan 22, 2010 |
| 8-K/A |
Amended current report
Acquisition or sale of assets, Unregistered share sale, Change in control, Regulation FD disclosure
|
Jan 19, 2010 | Oct 15, 2009 |
| 8-K |
Current report
Unregistered share sale
|
Nov 18, 2009 | Nov 12, 2009 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 6, 2009 | Nov 2, 2009 |
| 8-K |
Current report
Acquisition or sale of assets, Change in control, Officer or director change, Regulation FD disclosure
|
Oct 20, 2009 | Oct 15, 2009 |
Showing 102 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SBFM (Nasdaq), SBFMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Fort Lauderdale, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1402328
- Former names
- Sunshine Biopharma, Inc (until Oct 17, 2024); Mountain West Business Solutions, Inc (until Nov 2, 2009); mountain west business solutions,inc (until Oct 19, 2007); mountain state business solutions,inc (until May 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.